Treatment of osteoporsis, Paget's disease and other bone mineral density disesases using calcitonin and DHEA (an androgen)

A pharmaceutical formulation and it's use comprising a calcitonin-like agent and a dehydroepiandrosterone (DHEA)- like agent for the preparation of a pharmaceutical composition for increasing an individual's bone mineral density (BMD) wherein said medicament is formulated to provide the ca...

Full description

Saved in:
Bibliographic Details
Main Author SCHWARTZ, KENNETH E
Format Patent
LanguageEnglish
Published 26.03.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical formulation and it's use comprising a calcitonin-like agent and a dehydroepiandrosterone (DHEA)- like agent for the preparation of a pharmaceutical composition for increasing an individual's bone mineral density (BMD) wherein said medicament is formulated to provide the calcitonin-like and DHEA-like agents in an amount effective to increase BMD, and wherein administration of said medicament potentiates any increase in BMD achieved by administration of a similar amount of a calcitonin-like agent alone.
Bibliography:Application Number: NZ20000518791